PT1232183E - Peptidos possuindo actividade anti-angiogenica - Google Patents

Peptidos possuindo actividade anti-angiogenica

Info

Publication number: PT1232183E
Authority: PT; Portugal
Prior art keywords: peptidos; angiogenic activity; possessing anti; angiogenesis; inhibiting
Prior art date: 1999-11-22

Application number

PT00982219T

Other languages

English (en)

Inventor

Haviv Fortuna

Jack Henkin

Michael F Bradley

Douglas M Kalvin

Andrew J Schneider

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-22

Filing date

2000-11-22

Publication date

2006-06-30

2000-11-22 Application filed by Abbott Lab filed Critical Abbott Lab

2006-06-30 Publication of PT1232183E publication Critical patent/PT1232183E/pt

Links

230000001772 anti-angiogenic effect Effects 0.000 title 1
230000033115 angiogenesis Effects 0.000 abstract 3
230000002401 inhibitory effect Effects 0.000 abstract 3
241000124008 Mammalia Species 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT00982219T 1999-11-22 2000-11-22 Peptidos possuindo actividade anti-angiogenica PT1232183E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US44722599A	1999-11-22	1999-11-22
US70903400A	2000-11-08	2000-11-08

Publications (1)

Publication Number	Publication Date
PT1232183E true PT1232183E (pt)	2006-06-30

Family

ID=27034912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT00982219T PT1232183E (pt)	1999-11-22	2000-11-22	Peptidos possuindo actividade anti-angiogenica

Country Status (12)

Country	Link
EP (1)	EP1232183B1 (pt)
JP (1)	JP2003530313A (pt)
AT (1)	ATE316102T1 (pt)
CA (1)	CA2391386A1 (pt)
CY (1)	CY1106074T1 (pt)
DE (1)	DE60025648T2 (pt)
DK (1)	DK1232183T3 (pt)
ES (1)	ES2256071T3 (pt)
HK (1)	HK1050012B (pt)
MX (1)	MXPA02005150A (pt)
PT (1)	PT1232183E (pt)
WO (1)	WO2001038347A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020183242A1 (en) *	2001-04-11	2002-12-05	Jack Henkin	Peptide antiangiogenic drugs
US20030119746A1 (en) *	2001-10-31	2003-06-26	Fortuna Haviv	Hepta-and octapeptides having antiangiogenic activity
US20030125260A1 (en) *	2001-10-31	2003-07-03	Fortuna Haviv	Tetra-and pentapeptides having antiangiogenic activity
US7037897B2 (en)	2001-10-31	2006-05-02	Abbott Laboratories	TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US7067490B2 (en)	2001-10-31	2006-06-27	Abbott Laboratories	Hepta-, Octa-and nonapeptides having antiangiogenic activity
US7001984B2 (en)	2001-10-31	2006-02-21	Abbott Laboratories	Di-, tri-, and tetra-peptides having antiangiogenic activity
US7169888B2 (en)	2001-10-31	2007-01-30	Abbott Laboratories	Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US20030125259A1 (en)	2001-10-31	2003-07-03	Fortuna Haviv	Octa- and nonapeptides having antiangiogenic activity
US7122625B2 (en)	2001-10-31	2006-10-17	Abbott Laboratories	Hexa-, hepta-, and octapeptides having antiangiogenic activity
US20030228365A1 (en) *	2002-06-07	2003-12-11	Fortuna Haviv	Pharmaceutical formulation
EP1853294A4 (en)	2005-03-03	2010-01-27	Covx Technologies Ireland Ltd	ANTIANGIOGENIC COMPOUNDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5200397A (en) *	1990-02-22	1993-04-06	W. R. Grace & Co.-Conn.	Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
CA2255661C (en) *	1997-03-17	2004-08-10	Abbott Laboratories	Antiangiogenic drug to treat cancer, arthritis and retinopathy

2000
- 2000-11-22 DK DK00982219T patent/DK1232183T3/da active
- 2000-11-22 AT AT00982219T patent/ATE316102T1/de not_active IP Right Cessation
- 2000-11-22 CA CA002391386A patent/CA2391386A1/en not_active Abandoned
- 2000-11-22 WO PCT/US2000/032217 patent/WO2001038347A2/en not_active Ceased
- 2000-11-22 MX MXPA02005150A patent/MXPA02005150A/es active IP Right Grant
- 2000-11-22 PT PT00982219T patent/PT1232183E/pt unknown
- 2000-11-22 ES ES00982219T patent/ES2256071T3/es not_active Expired - Lifetime
- 2000-11-22 DE DE60025648T patent/DE60025648T2/de not_active Expired - Fee Related
- 2000-11-22 JP JP2001540110A patent/JP2003530313A/ja not_active Withdrawn
- 2000-11-22 EP EP00982219A patent/EP1232183B1/en not_active Expired - Lifetime
- 2000-11-22 HK HK03100425.2A patent/HK1050012B/en not_active IP Right Cessation
2006
- 2006-03-31 CY CY20061100453T patent/CY1106074T1/el unknown

Also Published As

Publication number	Publication date
CA2391386A1 (en)	2001-05-31
EP1232183A2 (en)	2002-08-21
WO2001038347A2 (en)	2001-05-31
DE60025648T2 (de)	2006-09-14
HK1050012B (en)	2006-09-08
EP1232183B1 (en)	2006-01-18
ATE316102T1 (de)	2006-02-15
MXPA02005150A (es)	2003-01-28
HK1050012A1 (en)	2003-06-06
CY1106074T1 (el)	2011-06-08
JP2003530313A (ja)	2003-10-14
DK1232183T3 (da)	2006-05-29
DE60025648D1 (de)	2006-04-06
ES2256071T3 (es)	2006-07-16
WO2001038347A3 (en)	2001-11-29

Publication	Publication Date	Title
DE60019577D1 (de)	2005-05-25	4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE295081T1 (de)	2005-05-15	Hilfsstoff-zusammensetzung
DE69922267D1 (de)	2004-12-30	Bewegliches zusammensetzspiel
DE60021371D1 (de)	2005-08-25	Piperidinderivate verwendbar als ccr5 antagonisten
PT1165069E (pt)	2005-01-31	Composicao sinergistica antitumoral
DE60131971D1 (de)	2008-01-31	1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
DE69708120D1 (de)	2001-12-13	Laser-absorbierende, lichtbleichbare zusammensetzungen
AR023440A1 (es)	2002-09-04	Composiciones antitranspirantes
DE60013221D1 (de)	2004-09-30	Fotopolymerisierbare Zusammensetzung
NO20014607D0 (no)	2001-09-21	Sammensetninger til forbedring av fertilitet
DE60019927D1 (de)	2005-06-09	Modifizierte alkylarylsulfonat-tenside enthaltende reinigungsmittelzusammensetzungen
ID29785A (id)	2001-10-11	Komposisi-komposisi sampo
ATE257691T1 (de)	2004-01-15	Schweisshemmende zusammensetzungen
DE50006919D1 (de)	2004-08-05	Femurschlitten
DE60008524D1 (de)	2004-04-01	Furanonderivate als inhibitoren von cathepsin s
DE69931821D1 (de)	2006-07-20	Wärmehärtbare pulverlack-zusammensetzung
DE69943245D1 (de)	2011-04-14	Gaserzeugende zusammensetzung
DE60035436D1 (de)	2007-08-16	Aerosolzusammensetzung
ATE316102T1 (de)	2006-02-15	Peptide mit antiangiogener aktivität
DE60036959D1 (de)	2007-12-13	Tensidzusammensetzungen, verbesserungsmittel enthaltend
DE50010265D1 (de)	2005-06-16	Azidfreie gaserzeugende Zusammensetzung
SE9904404D0 (sv)	1999-12-03	Novel composition
BR0010934A (pt)	2002-12-17	Peptìdeos n-alquilados possuindo atividade antiangiogênica
ID30272A (id)	2001-11-15	Komposisi resorsinol
DE60005188D1 (de)	2003-10-16	Grf-haltige lyophilisierte arzneizusammensetzungen